In conclusion, flavanones exert their anti-RCC effects by targeting multiple oncogenic pathways, such as PI3K/AKT/mTOR, COX-2/PGE2, and EGFR, while promoting oxidative stress and inhibiting angiogenesis. Here, MTOR is linked to renal cell carcinoma.